Conceiving, conducting, reporting, interpreting, and publishing disproportionality analyses: A call to action
Open Access
- 17 February 2022
- journal article
- letter
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 88 (7) , 3535-3536
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Adverse events of alpelisib: A postmarketing study of the World Health Organization pharmacovigilance databaseBritish Journal of Clinical Pharmacology, 2021
- A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databasesJournal of Clinical Epidemiology, 2021
- High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological studyJournal of Clinical Epidemiology, 2021
- Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection PerformancesFrontiers in Pharmacology, 2021
- Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancerAnnals of Oncology, 2020